The Board of Directors of SKAN Group AG has proposed Dr. Christian Schlogel as a new member for election at the Annual General Meeting on May 7, 2026, while Patrick Schar will not stand for re-election after 16 years of service. Dr. Schlogel, a German citizen born in 1964, brings three decades of leadership experience in global technology, software, and industrial companies, with expertise in digital transformation and artificial intelligence. His background includes roles as Group Chief Digital Officer at Korber AG from 2018 to 2025, where he led digital initiatives for approximately 14,000 employees, and as Group Chief Technology & Digital Officer at KUKA AG from 2014 to 2018, overseeing automation and robotics for around 15,000 employees. He currently serves on various administrative and advisory boards and began his career at SAP AG, holding a computer science degree from the Karlsruhe Institute of Technology and a doctorate in business administration from the University of Passau.
Beat Lüthi, Chairman of the Board of Directors, emphasized the strategic importance of this move, stating that SKAN is expanding its offerings to include software and digital integration services, a direction underscored by the company's majority stake acquisition in Metronik last year. Lüthi noted that Dr. Schlogel's expertise is expected to significantly support these initiatives, which are core to the strategy for future sales and margin growth. This nomination reflects SKAN's commitment to enhancing its digital capabilities in the competitive pharmaceutical manufacturing landscape, where the company is a market leader in aseptic and aseptic-toxic processes for the (bio)pharmaceutical industry. More details on the company's operations can be found at www.newmediawire.com.
Patrick Schar's decision not to seek re-election is attributed to professional reasons, with Lüthi acknowledging his 16-year tenure and contributions as a financial expert to SKAN Group's development. The company expressed gratitude for Schar's commitment and collaboration, wishing him well in his future endeavors. SKAN, founded in 1968 and employing close to 1,700 people globally, continues to focus on innovative solutions and life-cycle support for pharmaceutical and biotech clients, with its headquarters in Allschwil, Switzerland. The proposed board change aligns with broader industry trends toward digitalization, positioning SKAN to maintain its leadership in high-quality isolator systems and related services. This strategic shift could influence the company's ability to adapt to evolving market demands and technological advancements in the sector.
